title: Supportive therapy in multiple myeloma.
abstract: In this chapter we want to give an overview on various supportive measures, which help to prevent or to fight complications of multiple myeloma, improve patient wellbeing and increase safety of administration of specific anti-myeloma therapy.
authors.affiliation: Department of Medicine I, Wilhelminenspital, Montleartstr. 37, 1160, Vienna, Austria. heinz.ludwig@wienkav.at
authors.forename: Heinz
authors.initials: H
authors.lastname: Ludwig
authors.forename: Niklas
authors.initials: N
authors.lastname: Zojer
mesh_terms: D000740:Anemia / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D001803:Blood Transfusion; D001847:Bone Diseases / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D002116:Calcitonin / Q000627:therapeutic use; D004002:Clodronic Acid / Q000009:adverse effects / Q000627:therapeutic use; D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use; D004921:Erythropoietin / Q000627:therapeutic use; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D006397:Hematinics; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology / Q000628:therapy; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000150:complications* / Q000628:therapy*; D010024:Osteoporosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D000077268:Pamidronate; D011994:Recombinant Proteins; D051437:Renal Insufficiency / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D000077211:Zoledronic Acid
chemical_list: D004164:Diphosphonates; D006397:Hematinics; D007093:Imidazoles; D011994:Recombinant Proteins; D004002:Clodronic Acid; D004921:Erythropoietin; D000077211:Zoledronic Acid; D002116:Calcitonin; D000077268:Pamidronate